Europe Influenza Vaccine Market Size & Growth Rate
According to 6Wresearch internal database and industry insights, the Europe Influenza Vaccine Market was accounted at USD 1.25 billion in 2024 and is projected to reach nearly USD 3.01 billion by 2031, exhibiting a compound annual growth rate (CAGR) of 6.4% during the forecast period (2025-2031).
Europe Influenza Vaccine Market Highlights
| Report Name | Europe Influenza Vaccine Market |
| Forecast period | 2025-2031 |
| CAGR | 6.4% |
| Market Size | USD 3.01 billion by 2031 |
| Growing Sector | Healthcare & Pharmaceutical |
Topics Covered in the Europe Influenza Vaccine Market Report
Europe Influenza Vaccine Market report thoroughly covers the market by vaccine type, technology, age group, route of administration, and countries. The market report provides an unbiased and detailed analysis of ongoing market trends, opportunities/high growth areas, and market drivers, which would help stakeholders to devise and align their market strategies according to the current and future market dynamics.
Europe Influenza Vaccine Market Synopsis
Europe Influenza Vaccine Market is expected to grow vigorously in the upcoming years, due to more people getting cognizant of seasonal flu and government conducting vaccination programs. Nations are spending more on healthcare sector. Growing focus among countries across Europe to protect children, adults, and seniors through wider vaccinations. Additionally, advancements in technology are making vaccines safer and more effective encouraging higher adoption by healthcare providers backed by government programs for prevention and disease management.
Evaluation of Growth Drivers in the Europe Influenza Vaccine Market
Below are some prominent drivers and their influence on market dynamics:
| Drivers | Primary Segments Affected | Why It Matters (Evidence) |
| Government Immunization Programs | All vaccine types | Germany and UK vaccination programs boost flu vaccine adoption among high-risk groups. |
| Increasing Seasonal Flu Incidence | Adult, Pediatric Age Groups | Seasonal influenza outbreaks drive hospitals and clinics to conduct regular vaccination drives. |
| Technological Advancements | Egg-based, Cell-based | New vaccine tech: Cell-based and recombinant enhance vaccine safety, effectiveness, and production speed. |
| Awareness & Education Campaigns | Adult, Pediatric Age Groups | Awareness and education campaigns encourage more people to get vaccinated across Europe. |
| Rising Healthcare Expenditure | All vaccine types | Higher healthcare spending supports broader vaccine access and immunization programs. |
The Europe Influenza Vaccine Market is projected to grow at a CAGR of 6.4% during the forecast period of 2025-2031. The market is driven by several key factors which include increased awareness among all kind of age groups about seasonal flu and the need for preventive measures such as on-time vaccination. Governments through initiatives and programs are constantly urging people for vaccination. Improved accessibility achieved through higher spending on healthcare sector covering wide range of hospitals, clinics, and community health centers is further boosting growth. Advances in vaccine technology; the cell-based and recombinant methods due to their higher safety and effectiveness features are getting popular and encouraging wider use of adoption among healthcare providers.
Evaluation of Restraints in the Europe Influenza Vaccine Market
Below are some major restraints and their influence on market dynamics:
| Restraints | Primary Segments Affected | What This Means (Evidence) |
| High Vaccine Costs | Quadrivalent, Trivalent | High vaccine costs limit use in low-income areas. |
| Vaccine Hesitancy | Pediatric, Adult Age Groups | Misinformation and safety fears reduce vaccine acceptance. |
| Cold Chain & Storage Requirements | All types | Cold chain needs to raise costs and hinder distribution. |
| Supply Chain Disruptions | All vaccine types | Supply delays affect vaccine availability in flu season. |
| Regulatory Challenges | All vaccine types | Strict EU regulations slow product approvals and launches. |
Europe Influenza Vaccine Market Challenges
There are significant hurdles faced by the Europe Influenza Vaccine Industry. Expensive vaccines, supply chain problems and stringent regulations can slow down on-time distribution. Some people may be hesitant to get vaccinated due to lack of education and awareness. Poor cold storage facilities obstruct the reach to rural regions. Companies must ensure steady supply while complying with regulations, along with promoting vaccination benefits through programs to support market growth.
Europe Influenza Vaccine Market Trends
There are several notable trends shaping the market dynamics:
- Shift to Quadrivalent Vaccines: Increasing Demand for quadrivalent vaccines as they offer broader protection against four flu strains.
- Cell-based and Recombinant Technologies: Modern production methods improve vaccine strength, cut mutation risks, and speed up supply.
- Focus on High-risk Age Groups: Expanded vaccination drives for children, adults, and seniors are boosting coverage and reducing flu-related hospitalizations.
- Combination Vaccines: Dual-purpose vaccines, such as flu + COVID-19 or flu + pneumococcal, are improving convenience and uptake.
- Public Awareness Programs: Health campaigns and educational efforts are increasing public trust and participation in vaccination.
Investment Opportunities in the Europe Influenza Vaccine Market
Potential investment opportunities in the Europe Influenza Vaccine Market include:
- Quadrivalent Vaccine Expansion: Increasing production to supply vaccines that offer wider flu protection.
- Advanced Technologies: Using cell-based and recombinant methods to make vaccines stronger and faster to produce.
- Cold Chain Systems: Improving storage and transport to deliver vaccines safely across Europe.
- Health Awareness Programs: Supporting education and government efforts to raise vaccination rates.
- Combination Vaccines: Creating multi-use vaccines for better coverage and easier patient use.
Top 5 Leading Players in the Europe Influenza Vaccine Market
Some leading players dominating the Europe Influenza Vaccine Market Share include:
1. GlaxoSmithKline (GSK)
| Company Name | GlaxoSmithKline (GSK) |
| Establishment Year | 2000 |
| Headquarter | Brentford, United Kingdom |
| Official Website | Click here |
Global leader in influenza vaccines offering a wide range of quadrivalent and seasonal vaccines, focusing on innovation, high efficacy, and wide European distribution.
2. Sanofi Pasteur
| Company Name | Sanofi Pasteur |
| Establishment Year | 2004 |
| Headquarter | Lyon, France |
| Official Website | Click here |
Specializes in trivalent and quadrivalent influenza vaccines, leveraging advanced egg-based and recombinant technologies, and strong government partnerships across Europe.
3. Seqirus
| Company Name | Seqirus |
| Establishment Year | 2015 |
| Headquarter | Maidenhead, United Kingdom |
| Official Website | Click here |
Key player in cell-based and recombinant influenza vaccines, providing seasonal flu vaccines for adult and pediatric populations across Europe.
4. Abbott Laboratories
| Company Name | Abbott Laboratories |
| Establishment Year | 1888 |
| Headquarter | Abbott Park, Illinois, United States |
| Official Website | Click here |
Offers influenza vaccines and diagnostic solutions, focusing on innovative technologies and preventive healthcare solutions in Europe.
5. Bavarian Nordic
| Company Name | Bavarian Nordic |
| Establishment Year | 1994 |
| Headquarter | Kvistgaard, Denmark |
| Official Website | Click here |
Provides influenza vaccines including pandemic and seasonal options, emphasizing cell-based technologies and rapid production capabilities.
Government Regulations Introduced in the Europe Influenza Vaccine Market
Governments across Europe have implemented policies to support influenza vaccination and preventive healthcare. Examples include Germany’s National Immunization Plan: Promotes nationwide flu shots through funding and public awareness. UK NHS Seasonal Flu Program: Provides free yearly flu vaccines to priority groups. France’s Vaccination Strategy for High-Risk Groups: Offers low-cost flu shots for high-risk people. Italy’s National Vaccine Prevention Plan: Expands flu vaccine access nationwide. European Commission Recommendations on Seasonal Influenza Vaccination Coverage: Urges countries to vaccinate most high-risk people.
Future Insights of the Europe Influenza Vaccine Market
The future of the Europe Influenza Vaccine Market Growth looks optimistic due to increasing awareness about flu prevention supported by government initiatives that are working on increasing the reach of vaccination in all areas. Technological advancements especially the focus on quadrivalent and cell-based vaccines will drive strong market growth in the upcoming years. Awareness programs are reminding people to get vaccinated each year. Henceforth, this governments and manufacturers partnership will propel Europe’s vaccine supply.
Market Segmentation Analysis
The report offers a comprehensive study of the subsequent market segments and their leading categories.
Quadrivalent to Dominate the Market - by Vaccine Type
According to Priya, Senior Research Analyst, 6Wresearch, Quadrivalent vaccines, which protect against two influenza A strains and two influenza B strains, are expected to dominate due to broader coverage and higher adoption by national immunization programs.
Seasonal Influenza Vaccines to Lead the Market - by Type
Seasonal vaccines hold the largest market share, supported by annual vaccination campaigns for pediatric, adult, and elderly populations. Growing awareness of yearly flu risks and strong government procurement programs drive their widespread adoption.
Egg-based Vaccines to Dominate the Market - by Technology
Egg-based vaccines remain the most widely used due to established production methods, regulatory approval, and cost-effectiveness, though cell-based vaccines are growing in adoption.
Adult Segment to Lead by Age Group
The adult population, particularly high-risk adults over 50, dominates vaccine uptake, driven by public health initiatives and government vaccination programs. Increasing workplace immunization drives and awareness campaigns further strengthen vaccination.
Injection to Dominate by Route of Administration
Injectable vaccines lead the market due to their efficacy, regulatory approval, and wide acceptance among healthcare providers. Ongoing improvements in injection delivery systems and wider availability support their continued dominance.
Germany to Dominate the Europe Market by Countries
Germany is projected to hold the largest market share owing to strong immunization programs, high healthcare expenditure, and large adult and elderly populations targeted for vaccination.
Key Attractiveness of the Report
- 10 Years Market Numbers
- Historical Data Starting from 2021 to 2024
- Base Year: 2024
- Forecast Data until 2031
- Key Performance Indicators Impacting the Market
- Major Upcoming Developments and Projects
Key Highlights of the Report:
- Europe Influenza Vaccine Market Outlook
- Market Size of Europe Influenza Vaccine Market, 2024
- Forecast of Europe Influenza Vaccine Market, 2031
- Historical Data and Forecast of Europe Influenza Vaccine Revenues & Volume for the Period 2021 - 2031
- Europe Influenza Vaccine Market Trend Evolution
- Europe Influenza Vaccine Market Drivers and Challenges
- Europe Influenza Vaccine Price Trends
- Europe Influenza Vaccine Porter's Five Forces
- Europe Influenza Vaccine Industry Life Cycle
- Historical Data and Forecast of Europe Influenza Vaccine Market Revenues & Volume By Vaccine type for the Period 2021 - 2031
- Historical Data and Forecast of Europe Influenza Vaccine Market Revenues & Volume By Quadrivalent for the Period 2021 - 2031
- Historical Data and Forecast of Europe Influenza Vaccine Market Revenues & Volume By Trivalent for the Period 2021 - 2031
- Historical Data and Forecast of Germany Influenza Vaccine Market Revenues & Volume By Vaccine type for the Period 2021 - 2031
- Historical Data and Forecast of Germany Influenza Vaccine Market Revenues & Volume By Quadrivalent for the Period 2021 - 2031
- Historical Data and Forecast of Germany Influenza Vaccine Market Revenues & Volume By Trivalent for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Influenza Vaccine Market Revenues & Volume By Vaccine type for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Influenza Vaccine Market Revenues & Volume By Quadrivalent for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Influenza Vaccine Market Revenues & Volume By Trivalent for the Period 2021 - 2031
- Historical Data and Forecast of France Influenza Vaccine Market Revenues & Volume By Vaccine type for the Period 2021 - 2031
- Historical Data and Forecast of France Influenza Vaccine Market Revenues & Volume By Quadrivalent for the Period 2021 - 2031
- Historical Data and Forecast of France Influenza Vaccine Market Revenues & Volume By Trivalent for the Period 2021 - 2031
- Historical Data and Forecast of Italy Influenza Vaccine Market Revenues & Volume By Vaccine type for the Period 2021 - 2031
- Historical Data and Forecast of Italy Influenza Vaccine Market Revenues & Volume By Quadrivalent for the Period 2021 - 2031
- Historical Data and Forecast of Italy Influenza Vaccine Market Revenues & Volume By Trivalent for the Period 2021 - 2031
- Historical Data and Forecast of Russia Influenza Vaccine Market Revenues & Volume By Vaccine type for the Period 2021 - 2031
- Historical Data and Forecast of Russia Influenza Vaccine Market Revenues & Volume By Quadrivalent for the Period 2021 - 2031
- Historical Data and Forecast of Russia Influenza Vaccine Market Revenues & Volume By Trivalent for the Period 2021 - 2031
- Historical Data and Forecast of Spain Influenza Vaccine Market Revenues & Volume By Vaccine type for the Period 2021 - 2031
- Historical Data and Forecast of Spain Influenza Vaccine Market Revenues & Volume By Quadrivalent for the Period 2021 - 2031
- Historical Data and Forecast of Spain Influenza Vaccine Market Revenues & Volume By Trivalent for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Influenza Vaccine Market Revenues & Volume By Vaccine type for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Influenza Vaccine Market Revenues & Volume By Quadrivalent for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Influenza Vaccine Market Revenues & Volume By Trivalent for the Period 2021 - 2031
- Historical Data and Forecast of Europe Influenza Vaccine Market Revenues & Volume By Type for the Period 2021 - 2031
- Historical Data and Forecast of Europe Influenza Vaccine Market Revenues & Volume By Seasonal for the Period 2021 - 2031
- Historical Data and Forecast of Europe Influenza Vaccine Market Revenues & Volume By Pandemic for the Period 2021 - 2031
- Historical Data and Forecast of Germany Influenza Vaccine Market Revenues & Volume By Type for the Period 2021 - 2031
- Historical Data and Forecast of Germany Influenza Vaccine Market Revenues & Volume By Seasonal for the Period 2021 - 2031
- Historical Data and Forecast of Germany Influenza Vaccine Market Revenues & Volume By Pandemic for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Influenza Vaccine Market Revenues & Volume By Type for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Influenza Vaccine Market Revenues & Volume By Seasonal for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Influenza Vaccine Market Revenues & Volume By Pandemic for the Period 2021 - 2031
- Historical Data and Forecast of France Influenza Vaccine Market Revenues & Volume By Type for the Period 2021 - 2031
- Historical Data and Forecast of France Influenza Vaccine Market Revenues & Volume By Seasonal for the Period 2021 - 2031
- Historical Data and Forecast of France Influenza Vaccine Market Revenues & Volume By Pandemic for the Period 2021 - 2031
- Historical Data and Forecast of Italy Influenza Vaccine Market Revenues & Volume By Type for the Period 2021 - 2031
- Historical Data and Forecast of Italy Influenza Vaccine Market Revenues & Volume By Seasonal for the Period 2021 - 2031
- Historical Data and Forecast of Italy Influenza Vaccine Market Revenues & Volume By Pandemic for the Period 2021 - 2031
- Historical Data and Forecast of Russia Influenza Vaccine Market Revenues & Volume By Type for the Period 2021 - 2031
- Historical Data and Forecast of Russia Influenza Vaccine Market Revenues & Volume By Seasonal for the Period 2021 - 2031
- Historical Data and Forecast of Russia Influenza Vaccine Market Revenues & Volume By Pandemic for the Period 2021 - 2031
- Historical Data and Forecast of Spain Influenza Vaccine Market Revenues & Volume By Type for the Period 2021 - 2031
- Historical Data and Forecast of Spain Influenza Vaccine Market Revenues & Volume By Seasonal for the Period 2021 - 2031
- Historical Data and Forecast of Spain Influenza Vaccine Market Revenues & Volume By Pandemic for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Influenza Vaccine Market Revenues & Volume By Type for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Influenza Vaccine Market Revenues & Volume By Seasonal for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Influenza Vaccine Market Revenues & Volume By Pandemic for the Period 2021 - 2031
- Historical Data and Forecast of Europe Influenza Vaccine Market Revenues & Volume By Technology for the Period 2021 - 2031
- Historical Data and Forecast of Europe Influenza Vaccine Market Revenues & Volume By Egg-based for the Period 2021 - 2031
- Historical Data and Forecast of Europe Influenza Vaccine Market Revenues & Volume By Cell-based for the Period 2021 - 2031
- Historical Data and Forecast of Germany Influenza Vaccine Market Revenues & Volume By Technology for the Period 2021 - 2031
- Historical Data and Forecast of Germany Influenza Vaccine Market Revenues & Volume By Egg-based for the Period 2021 - 2031
- Historical Data and Forecast of Germany Influenza Vaccine Market Revenues & Volume By Cell-based for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Influenza Vaccine Market Revenues & Volume By Technology for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Influenza Vaccine Market Revenues & Volume By Egg-based for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Influenza Vaccine Market Revenues & Volume By Cell-based for the Period 2021 - 2031
- Historical Data and Forecast of France Influenza Vaccine Market Revenues & Volume By Technology for the Period 2021 - 2031
- Historical Data and Forecast of France Influenza Vaccine Market Revenues & Volume By Egg-based for the Period 2021 - 2031
- Historical Data and Forecast of France Influenza Vaccine Market Revenues & Volume By Cell-based for the Period 2021 - 2031
- Historical Data and Forecast of Italy Influenza Vaccine Market Revenues & Volume By Technology for the Period 2021 - 2031
- Historical Data and Forecast of Italy Influenza Vaccine Market Revenues & Volume By Egg-based for the Period 2021 - 2031
- Historical Data and Forecast of Italy Influenza Vaccine Market Revenues & Volume By Cell-based for the Period 2021 - 2031
- Historical Data and Forecast of Russia Influenza Vaccine Market Revenues & Volume By Technology for the Period 2021 - 2031
- Historical Data and Forecast of Russia Influenza Vaccine Market Revenues & Volume By Egg-based for the Period 2021 - 2031
- Historical Data and Forecast of Russia Influenza Vaccine Market Revenues & Volume By Cell-based for the Period 2021 - 2031
- Historical Data and Forecast of Spain Influenza Vaccine Market Revenues & Volume By Technology for the Period 2021 - 2031
- Historical Data and Forecast of Spain Influenza Vaccine Market Revenues & Volume By Egg-based for the Period 2021 - 2031
- Historical Data and Forecast of Spain Influenza Vaccine Market Revenues & Volume By Cell-based for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Influenza Vaccine Market Revenues & Volume By Technology for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Influenza Vaccine Market Revenues & Volume By Egg-based for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Influenza Vaccine Market Revenues & Volume By Cell-based for the Period 2021 - 2031
- Historical Data and Forecast of Europe Influenza Vaccine Market Revenues & Volume By Age Group for the Period 2021 - 2031
- Historical Data and Forecast of Europe Influenza Vaccine Market Revenues & Volume By Pediatric for the Period 2021 - 2031
- Historical Data and Forecast of Europe Influenza Vaccine Market Revenues & Volume By Adult for the Period 2021 - 2031
- Historical Data and Forecast of Germany Influenza Vaccine Market Revenues & Volume By Age Group for the Period 2021 - 2031
- Historical Data and Forecast of Germany Influenza Vaccine Market Revenues & Volume By Pediatric for the Period 2021 - 2031
- Historical Data and Forecast of Germany Influenza Vaccine Market Revenues & Volume By Adult for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Influenza Vaccine Market Revenues & Volume By Age Group for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Influenza Vaccine Market Revenues & Volume By Pediatric for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Influenza Vaccine Market Revenues & Volume By Adult for the Period 2021 - 2031
- Historical Data and Forecast of France Influenza Vaccine Market Revenues & Volume By Age Group for the Period 2021 - 2031
- Historical Data and Forecast of France Influenza Vaccine Market Revenues & Volume By Pediatric for the Period 2021 - 2031
- Historical Data and Forecast of France Influenza Vaccine Market Revenues & Volume By Adult for the Period 2021 - 2031
- Historical Data and Forecast of Italy Influenza Vaccine Market Revenues & Volume By Age Group for the Period 2021 - 2031
- Historical Data and Forecast of Italy Influenza Vaccine Market Revenues & Volume By Pediatric for the Period 2021 - 2031
- Historical Data and Forecast of Italy Influenza Vaccine Market Revenues & Volume By Adult for the Period 2021 - 2031
- Historical Data and Forecast of Russia Influenza Vaccine Market Revenues & Volume By Age Group for the Period 2021 - 2031
- Historical Data and Forecast of Russia Influenza Vaccine Market Revenues & Volume By Pediatric for the Period 2021 - 2031
- Historical Data and Forecast of Russia Influenza Vaccine Market Revenues & Volume By Adult for the Period 2021 - 2031
- Historical Data and Forecast of Spain Influenza Vaccine Market Revenues & Volume By Age Group for the Period 2021 - 2031
- Historical Data and Forecast of Spain Influenza Vaccine Market Revenues & Volume By Pediatric for the Period 2021 - 2031
- Historical Data and Forecast of Spain Influenza Vaccine Market Revenues & Volume By Adult for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Influenza Vaccine Market Revenues & Volume By Age Group for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Influenza Vaccine Market Revenues & Volume By Pediatric for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Influenza Vaccine Market Revenues & Volume By Adult for the Period 2021 - 2031
- Historical Data and Forecast of Europe Influenza Vaccine Market Revenues & Volume By Route of Administration for the Period 2021 - 2031
- Historical Data and Forecast of Europe Influenza Vaccine Market Revenues & Volume By Injection for the Period 2021 - 2031
- Historical Data and Forecast of Europe Influenza Vaccine Market Revenues & Volume By Nasal Spray for the Period 2021 - 2031
- Historical Data and Forecast of Germany Influenza Vaccine Market Revenues & Volume By Route of Administration for the Period 2021 - 2031
- Historical Data and Forecast of Germany Influenza Vaccine Market Revenues & Volume By Injection for the Period 2021 - 2031
- Historical Data and Forecast of Germany Influenza Vaccine Market Revenues & Volume By Nasal Spray for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Influenza Vaccine Market Revenues & Volume By Route of Administration for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Influenza Vaccine Market Revenues & Volume By Injection for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Influenza Vaccine Market Revenues & Volume By Nasal Spray for the Period 2021 - 2031
- Historical Data and Forecast of France Influenza Vaccine Market Revenues & Volume By Route of Administration for the Period 2021 - 2031
- Historical Data and Forecast of France Influenza Vaccine Market Revenues & Volume By Injection for the Period 2021 - 2031
- Historical Data and Forecast of France Influenza Vaccine Market Revenues & Volume By Nasal Spray for the Period 2021 - 2031
- Historical Data and Forecast of Italy Influenza Vaccine Market Revenues & Volume By Route of Administration for the Period 2021 - 2031
- Historical Data and Forecast of Italy Influenza Vaccine Market Revenues & Volume By Injection for the Period 2021 - 2031
- Historical Data and Forecast of Italy Influenza Vaccine Market Revenues & Volume By Nasal Spray for the Period 2021 - 2031
- Historical Data and Forecast of Russia Influenza Vaccine Market Revenues & Volume By Route of Administration for the Period 2021 - 2031
- Historical Data and Forecast of Russia Influenza Vaccine Market Revenues & Volume By Injection for the Period 2021 - 2031
- Historical Data and Forecast of Russia Influenza Vaccine Market Revenues & Volume By Nasal Spray for the Period 2021 - 2031
- Historical Data and Forecast of Spain Influenza Vaccine Market Revenues & Volume By Route of Administration for the Period 2021 - 2031
- Historical Data and Forecast of Spain Influenza Vaccine Market Revenues & Volume By Injection for the Period 2021 - 2031
- Historical Data and Forecast of Spain Influenza Vaccine Market Revenues & Volume By Nasal Spray for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Influenza Vaccine Market Revenues & Volume By Route of Administration for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Influenza Vaccine Market Revenues & Volume By Injection for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Influenza Vaccine Market Revenues & Volume By Nasal Spray for the Period 2021 - 2031
- Europe Influenza Vaccine Market - Key Performance Indicators
- Europe Influenza Vaccine Market - Import Export Trade Statistics
- Europe Influenza Vaccine Market - Opportunity Assessment By Countries
- Europe Influenza Vaccine Market - Opportunity Assessment By Vaccine type
- Europe Influenza Vaccine Market - Opportunity Assessment By Type
- Europe Influenza Vaccine Market - Opportunity Assessment By Technology
- Europe Influenza Vaccine Market - Opportunity Assessment By Age Group
- Europe Influenza Vaccine Market - Opportunity Assessment By Route of Administration
- Europe Influenza Vaccine Market - Top Companies Market Share
- Europe Influenza Vaccine Market - Top Companies Profiles
- Europe Influenza Vaccine Market - Comparison of Players in Technical and Operating Parameters
- Europe Influenza Vaccine Market - Strategic Recommendations
Market Scope and Segmentation
The report provides a detailed analysis of the following market segments:
By Vaccine Type
- Quadrivalent
- Trivalent
By Type
- Seasonal
- Pandemic
By Technology
- Egg-based
- Cell-based
By Age Group
- Pediatric
- Adult
By Route of Administration
- Injection
- Nasal Spray
By Countries
- Germany
- United Kingdom
- France
- Italy
- Russia
- Spain
- Rest of Europe
